BPSD THE AGITATED ELDERLY
|
|
- Agatha Wilkins
- 7 years ago
- Views:
Transcription
1 BPSD THE AGITATED ELDERLY GP Update August 2011 Dr. Carla Freeman Senior registrar Division of Neuropsychiatry Department of Psychiatry and Mental Health, University of Cape Town
2 2002: POPULATION >65YRS
3
4 BPSD OVERVIEW Occurs in 70-90% of dementia Symptoms differ depending on stage of dementia Aetiology: biological, psychological, environmental and social Decreased QOL and increased caregiver burden/distress leading to premature residential placement Good evidence supporting a number of non-pharmacological and pharmacological interventions
5 DEFINITION Behavioural Screaming Restlessness Wandering Physical aggression Agitation, apathy Disinhibition (e.g. sexual, culturally inappropriate) Sleep and appetite changes Hoarding, shadowing etc Psychological Mood disturbance: depression, irritability Anxiety esp. anticipatory Hallucinations Delusions
6 MANAGEMENT K E Y P R I N C I P L E S : 1. Differential diagnosis: Is this dementia? The 3D s
7 MANAGEMENT K E Y P R I N C I P L E S : 1. Is this dementia? 2. Consider contributing factors or triggers: Unrecognized or suboptimal management of pain 1 Physical health e.g. dehydration, glycemic control Side effects of medication e.g. constipation (amitriptyline), psychiatric complaints (corticosteroids), confusion(anticonvulsants, lithium, ciprofloxacin, cimetidine) Psychosocial and environmental changes Depression Relationships with carers, care-workers and family members Hearing or vision problems 1 BMJ 2011 ;343:d
8 MANAGEMENT K E Y P R I N C I P L E S 1. Is this dementia? 2. Consider contributing factors or triggers 3. Identify target problems: Allows to plan/formulate the best treatment approach Family: 24hr behaviour chart Monitoring of behaviour following treatment Rating scales to assist with management strategy Clear documentation in notes = essential
9 MANAGEMENT K E Y P R I N C I P L E S 1. Is this dementia? 2. Consider contributing factors or triggers 3. Identify target problems 4. Formulate the problem Develop an understanding of the target symptoms, their duration, possible underlying cause and treatment strategy. Communicate this to both the caregiver and the patient
10 MANAGEMENT OF BPSD
11 NON-PHARMACOLOGICAL INTERVENTIONS Considered first-line Empowers family Needs to be monitored and evaluated Fine balance between activity and over-stimulation
12 NON-PHARMACOLOGICAL MANAGEMENT Rigorous routine Environmental strategies Nursing care interventions Social contact Psychological therapies Avoid punishment!
13 PHARMACOLOGICAL MX Principles of prescribing: Full discussion with patient and care-giver about possible risks and benefits Undertake an individual risk-benefit analysis Start low, go slow Exclude exacerbating medical illness at each stage of treatment Fluctuating nature of BPSD attempt to withdraw meds if possible at appropriate time e.g. sedatives Withdraw drugs with poor response before instating a new drug (one at a time!) Remember drug interactions Record changes in symptoms and cognition regularly
14 AGITATION Definition: mixed-big mental disturbances or perturbation showing itself usually by physical excitement (Oxford University Press 2004) excessive motor activity associated with a feeling of inner tension (DSM IV) Inappropriate verbal, vocal, or motor activity that is not explained by needs or confusion per se. It includes behaviours such as aimless wandering, pacing, cursing, screaming, biting and fighting (Cohen- Mansfield 1986)
15 MANY FORMS OF AGITATION Physically non-aggressive General Restlessness Repetitive Mannerisms Pacing Hiding Objects Inappropriate Handling Shadowing Escaping protected environment Inappropriate Dressing/Undressing Verbally non-aggressive: chanting, constant interruptions and requests for attention Physically aggressive Hitting Pushing Scratching Grabbing Kicking Biting Spitting Verbally aggressive: screaming, swearing etc.
16 RULE NUMBER 3 S Y N D R O M E S F I R S T, S Y M P T O M S S E C O N D (courtesy of Dr John Joska) For Alzheimer s disease, use anti-dementia drugs before anti-psychotics For depression, use anti-depressants before antipsychotics For everything else, use other drugs before benzodiazepines
17 C O G N I T I V E E N H A N C E R S Cholinesterase inhibitors: Donepezil (Aricept/Ariknow ) 5-10mg nocte Rivastigmine (Exelon ) 3-6mg twice daily Galantamine (Reminyl ) 8-12mg twice daily Equal efficacy, tolerability may differ Mild to moderate DAT some use in severe and vascular dementia Shown to improve cognition, behaviour, functioning and delay placement 1/3 improve, 1/3 remain stable and 1/3 deteriorate
18 COGNITIVE ENHANCERS (2) NMDA receptor antagonists Memantine (Ebixa ) 5-20mg daily in divided doses Severe DAT, consider for vascular dementia Safe to use with Donepezil Monitor adverse effects Long term effect is unknown
19 AGITATION TREATMENT CONT. Antidepressants Antipsychotics Later Anticonvulsants Prominent mood features (previous BPMD/affective instability) ictal like outbursts Agitation unresponsive to other treatment Valproate 20mg/kg range mg/day divided doses High side effect profile (hair loss, weight gain, GIT, plts, osteoporosis?) Carbamazepine fallen out of favour, may be useful if other drugs are contraindicated) Lamotrigine increasing evidenc
20 DEPRESSION Common DAT: 0-20% have full syndrome, up to 50% have depressive symptoms Significantly impairs QOL, increases care-giver burden Increases mortality Features include: anhedonia, rejection sensitivity, self-pity and psychomotor disturbances Symptoms often fluctuate Commonly recurs
21 DEPRESSION: TREATMENT Avoid TCAs SSRIs are useful beware agitation Treatment response = longer Suggested regimens: Citalopram 10-20mg Mirtazapine 15-30mg Mianserin 30mg Venlafaxine 37.5mg (hypertension) Agomelatine??
22 ANXIETY Common: GAD, Godot syndrome, fear of being left alone, pacing, wringing hands. Avoid use of long term benzodiazepines dependence, cognitive deficits, falls Look for co-morbid depression treat with antidepressants Rational use of benzodiazepines if absolutely necessary
23 PSYCHOSIS Definition: Criteria for dementia are met + hallucinations or delusions or both Present intermittently for longer than one month and interfere with function. NB chronology Not due to another psychiatric illness or part of a delirium syndrome Bizarre or complex delusions are rare, misidentification syndromes are common Exclude epilepsy, intra cerebral pathology.
24 PSYCHOSIS: TREATMENT Antipsychotics are indicated for psychosis and severe agitation High side effect profile: First generation: EPSEs Second generation: Metabolic side effects Both: Risk of CVA Risk-benefit assessment and informed consent Risperidone 0.5mg bd, Quetiapine 25mg at night Not recommended for longer than 3 months, reassess regularly!
25 SLEEP DISTURBANCE Common: day-night reversal Non-pharmacological = NB: Keep awake during day Limit naps Sleep requirement decreases with age Stimulus control at night White noise Assist carer relief nights Pharmacological: Sedating antidepressants, anti-histamines, non-benzodiazepine hypnotics, melatonin.
26 ADDITIONAL PROBLEMATIC BEHAVIOURS Sexual disinhibition Cyproterone acetate (Androcur ) Substance dependence: Alcohol OTC analgesia Benzodiazepines Consider detox/withdrawal inpatient/outpatient rehab
27 WHEN TO REFER: Valkenberg Geriatric clinic: Memory Clinic: >60 years Graduates from adult psychiatry Unmanageable BPSD Fax: VBH OPD Att. Dr. Joska (021) Diagnostic dilemmas Unusual presentation/symptoms Full MDT evaluation Fax referral to Sonja Hendrix at IAA forms on internet
28 REFERENCES 1. Husebo BH, Ballard Clive et al. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomized control trial. BMJ 2011; 343:d Chen Y, Briesacher BA, Field TS et al. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med 2010; 170: Devanand DP, Schulz SK. Consequences of antipsychotic medications for the dementia patient. Am J Psychiatry 2011; 168: Howland RH. A benefit risk assessment of agomelatine in the treatment of major depression. Drug Saf 2011; 34(9): Australian Guidelines for BPSD Alzheimer Europe: Treatment for behavioural and psychological symptoms of dementia 2011
29 T HANK YOU! QUESTIONS?
Clinical Audit: Prescribing antipsychotic medication for people with dementia
Clinical Audit: Prescribing antipsychotic medication for people with dementia Trust, team and patient information Q1. Patient's DIS number... Q2. Patient s residence: Home Residential Home Nursing Home
More informationDementa Formulary Guidance [v1.0]
Dementa Formulary Guidance [v1.0] 1. Introduction These Guidelines are intended for routine use. However there will be instances where they are not suitable for the patient you are managing, where more
More informationThese guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes.
This is a new guideline. These guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes. It incorporates NICE clinical
More informationConjoint Professor Brian Draper
Chronic Serious Mental Illness and Dementia Optimising Quality Care Psychiatry Conjoint Professor Brian Draper Academic Dept. for Old Age Psychiatry, Prince of Wales Hospital, Randwick Cognitive Course
More informationEmergency Room Treatment of Psychosis
OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different
More informationPharmacotherapy of BPSD. Pharmacological interventions. Anti-dementia drugs. Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence
Pharmacotherapy of BPSD Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence Pharmacological interventions Reducing medication errors. Reducing potentially inappropriate medication prescription.
More informationUpdate on Treatment of the Dementias
Update on Treatment of the Dementias Mark Pippenger, MD Behavioral Neurology Associate Clinical Professor of Neurology University of Arkansas for Medical Sciences Disclosures I will be discussing off-label
More informationPrimary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment
Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate
More informationAntipsychotics in people with dementia an update and reminder
www.bpac.org.nz keyword: dementia Antipsychotics in people with dementia an update and reminder Key concepts: Non-pharmacological treatments for the behavioural and psychological symptoms of dementia (BPSD)
More informationAntipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers
SUPPLEMENT 1: (Supplementary Material for online publication) Antipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers About this
More informationMANAGEMENT OF DIFFICULT BEHAVIORS IN DEMENTIA
MANAGEMENT OF DIFFICULT BEHAVIORS IN DEMENTIA Danielle Hansen, DO, MS (Med Ed), MHSA Objectives Understand the prevalence of Behavioral and Psychological Symptoms of Dementia (BPSD) among individuals with
More informationadaptations whenever possible, to prevent or reduce the occurrence of challenging behaviours.
POSITION STATEMENT on Management of Challenging Behaviours in People with Dementia 1. AIM OF THE POSITION STATEMENT This position statement applies to people living in supported accommodation and those
More informationLong Term Care Formulary HCD - 09. Anti-Dementia Drugs (e.g. donepezil, galantamine, rivastigmine, memantine)
1 of 8 USE OF CHOLINESTERASE (AChE) INHIBITORS The cholinesterase inhibitor anti-dementia drugs are indicated for the symptomatic treatment of patients with mild to moderate dementia of the Alzheimer s
More informationRecognition and Treatment of Depression in Parkinson s Disease
Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,
More informationDepression Flow Chart
Depression Flow Chart SCREEN FOR DEPRESSION ANNUALLY Assess for depression annually with the PHQ-9. Maintain a high index of suspicion in high risk older adults. Consider suicide risk and contributing
More informationMemantine (Ebixa) Drug treatment for Alzheimer s disease
IS 20 October 2011 Information sheet Memantine (Ebixa) Drug treatment for Alzheimer s disease Introduction... 1 How does Ebixa work?... 1 Who might benefit?... 2 What effect might Ebixa have?... 2 How
More informationDementia End-of-Life Care
Dementia End-of-Life Care Dr. L. Badenhorst Riverview Health Centre Behaviour Management Chronic Care End-of-Life Care in Dementia Definitions Dementia Palliative Care End-of-Life care Challenges Diagnosing
More informationDEMENTIA EDUCATION & TRAINING PROGRAM
The pharmacological management of aggression in the nursing home requires careful assessment and methodical treatment to assure maximum safety for patients, nursing home residents and staff. Aggressive
More informationShared Care Protocol for the Prescription of Memantine for Alzheimer s disease
Shared Care Protocol for the Prescription of Memantine for Alzheimer s disease 1. REFERRAL CRITERIA Patients of any age that are suspected to be suffering from moderate to severe Alzheimer s disease will
More informationStandardised care process (SCP): depression
Standardised care process (SCP): depression Topic Identifying and responding to symptoms of depression Objective To promote evidence-based practice in how staff identify and respond to symptoms of depression
More informationDepression is a common biological brain disorder and occurs in 7-12% of all individuals over
Depression is a common biological brain disorder and occurs in 7-12% of all individuals over the age of 65. Specific groups have a much higher rate of depression including the seriously medically ill (20-40%),
More informationObjectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment
Dementia David Lam, MD, FRCPC, Psychiatry Assistant Clinical Professor Department of Psychiatry and Behavioural Neurosciences McMaster University Hamilton, Ontario Objectives Aging and Forgetfulness Define
More information**Form 1: - Consultant Copy** Telephone Number: Fax Number: Email: Author: Dr Bernard Udeze Pharmacist: Claire Ault Date of issue July 2011
Effective Shared Care Agreement for the treatment of Dementia in Alzheimer s Disease Donepezil tablets / orodispersible tablets (Aricept / Aricept Evess ) These forms (1 and 2) are to be completed by both
More informationDementia & Movement Disorders
Dementia & Movement Disorders A/Prof Michael Davis Geriatrician ACT Health & GSAHS ANU Medical School Eastern Dementia Network Aged and Dementia Care Symposium Bateman s Bay, 22 October 2010 Types of Dementia
More information`çããçå=jéåí~ä= aáëçêçéêëw=^åñáéíó=~åç= aééêéëëáçå. aêk=`=f=lâçåü~ jéçáå~ä=aáêéåíçê lñäé~ë=kep=cçìåç~íáçå=qêìëí=
`çããçå=jéåí~ä= aáëçêçéêëw=^åñáéíó=~åç= aééêéëëáçå aêk=`=f=lâçåü~ jéçáå~ä=aáêéåíçê lñäé~ë=kep=cçìåç~íáçå=qêìëí= Overview: Common Mental What are they? Disorders Why are they important? How do they affect
More informationDonepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer s disease (amended)
Issue date: November 2006 (amended September 2007, August 2009) Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer s disease (amended) Includes a review of NICE
More informationPharmacological Management of Neuropsychiatric Symptoms of Dementia
Pharmacological Management of Neuropsychiatric Symptoms of Dementia Dr. Dallas Seitz MD FRCPC Assistant Professor and Clinician Scientist, Department of Psychiatry Queen s University Department of Psychiatry
More informationAlgorithm for Initiating Antidepressant Therapy in Depression
Algorithm for Initiating Antidepressant Therapy in Depression Refer for psychotherapy if patient preference or add cognitive behavioural office skills to antidepressant medication Moderate to Severe depression
More informationAlzheimer's: The Latest Assessment and Treatment Strategies
Questions from chapter 1 Alzheimer's: The Latest Assessment and Treatment Strategies 1) What is a loss of cognitive and intellectual powers without changes in consciousness. a) dementia b) delusions c)
More informationComorbid Conditions in Autism Spectrum Illness. David Ermer MD June 13, 2014
Comorbid Conditions in Autism Spectrum Illness David Ermer MD June 13, 2014 Overview Diagnosing comorbidities in autism spectrum illnesses Treatment issues specific to autism spectrum illnesses Treatment
More informationCOUNTY OF LOS ANGELES - DEPARTMENT OF MENTAL HEALTH OFFICE OF THE MEDICAL DIRECTOR. 3.4 PARAMETERS FOR THE USE OF ANXIOLYTIC MEDICATIONS October 2014
COUNTY OF LOS ANGELES - DEPARTMENT OF MENTAL HEALTH OFFICE OF THE MEDICAL DIRECTOR 3.4 PARAMETERS FOR THE USE OF ANXIOLYTIC MEDICATIONS October 2014 I. GENERAL CONSIDERATIONS A. Definition: Anxiolytic
More informationPrescribing Framework for Donepezil in the Treatment and Management of Dementia
Hull & East Riding Prescribing Committee Prescribing Framework for Donepezil in the Treatment and Management of Dementia Patients Name:.. NHS Number: Patients Address:... (Use addressograph sticker) GP
More informationTREATMENT-RESISTANT DEPRESSION AND ANXIETY
University of Washington 2012 TREATMENT-RESISTANT DEPRESSION AND ANXIETY Catherine Howe, MD, PhD University of Washington School of Medicine Definition of treatment resistance Failure to remit after 2
More information4 DRUGS USED TO RELIEVE BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA
DEMENTIA Q&A 4 DRUGS USED TO RELIEVE BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA People with dementia may at some point in their illness develop behavioural or psychological symptoms. While it is
More informationDEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE
1 DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE ASSESSMENT/PROBLEM RECOGNITION 1. Did the staff and physician seek and document risk factors for depression and any history of depression? 2. Did staff
More informationNHS ONEL and NELFT Shared Care Guidelines. Management of medications for Alzheimer s disease. Patient Name : Date of Birth: NHS No:
NHS ONEL and NELFT Shared Care Guidelines Management of medications for Alzheimer s disease DOCUMENT TO BE SCANNED INTO ELECTRONIC RECORDS AND FILED IN NOTES Patient Name : Date of Birth: NHS No: Name
More informationMental Health & Substance Use Disorders
Mental Health & Substance Use Disorders Thank you to Daniella Kanareck Dr. Arielle Taylor Overview 1. Overview of Mental Health 2. Stigma and attitudes associated with this population 3. Mental Disorders
More informationDisclosure Statement. Nursing Facility Regulations and Psychotropic Medication Use. Learning Objectives (Cont) Learning Objectives
Nursing Facility Regulations and Psychotropic Medication Use Jeffrey C. Reist PharmD, BCPS College of Pharmacy The University of Iowa December 2010 Disclosure Statement I, Jeffrey Reist, PharmD, BCPS do
More informationRecognizing and Treating Depression in Children and Adolescents.
Recognizing and Treating Depression in Children and Adolescents. KAREN KANDO, MD Division of Child and Adolescent Psychiatry Center for Neuroscience and Behavioral Medicine Phoenix Children s Hospital
More informationTechnology appraisal guidance Published: 23 March 2011 nice.org.uk/guidance/ta217
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease Technology appraisal guidance Published: 23 March 2011 nice.org.uk/guidance/ta217 NICE 2011. All rights reserved.
More informationShared Care Guideline-Use of Donepezil, Galantamine, Rivastigmine and Memantine in Dementia
Shared Care Guideline-Use of Donepezil, Galantamine, Rivastigmine and Memantine in Dementia Version: 3.0 Ratified by: Medicines Committee Date ratified: 16 th November 2011 Name of originator/author: James
More informationTREATING MAJOR DEPRESSIVE DISORDER
TREATING MAJOR DEPRESSIVE DISORDER A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition, originally published in April 2000.
More informationMOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION
MOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION Executive summary of recommendations Details of recommendations can be found in the main text at the pages indicated. Clinical evaluation D The basic
More informationHow To Treat An Elderly Patient
1. Introduction/ Getting to know our Seniors a. Identify common concepts and key terms used when discussing geriatrics b. Distinguish between different venues of senior residence c. Advocate the necessity
More informationAlzheimer s and Depression: What is the Connection?
Alzheimer s and Depression: What is the Connection? Ladson Hinton MD Professor and Director of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Director, Education Core, Alzheimer
More informationin young people Management of depression in primary care Key recommendations: 1 Management
Management of depression in young people in primary care Key recommendations: 1 Management A young person with mild or moderate depression should typically be managed within primary care services A strength-based
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder,
More informationDonepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease
IS 11 October 2011 Information sheet Donepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease Introduction... 1 How does Aricept work?... 1 Who might benefit from Aricept?... 2 What effect
More informationIMR ISSUES, DECISIONS AND RATIONALES The Final Determination was based on decisions for the disputed items/services set forth below:
Case Number: CM13-0018009 Date Assigned: 10/11/2013 Date of Injury: 06/11/2004 Decision Date: 01/13/2014 UR Denial Date: 08/16/2013 Priority: Standard Application Received: 08/29/2013 HOW THE IMR FINAL
More informationDepression in the Elderly: Recognition, Diagnosis, and Treatment
Depression in the Elderly: Recognition, Diagnosis, and Treatment LOUIS A. CANCELLARO, PhD, MD, EFAC Psych Professor Emeritus and Interim Chair ETSU Department of Psychiatry & Behavioral Sciences Diagnosis
More informationDonepezil (Aricept ), Galantamine (Reminyl XL ), Rivastigmine (Exelon ) and Memantine (Ebixa )
Donepezil (Aricept ), Galantamine (Reminyl XL ), Rivastigmine (Exelon ) and Memantine (Ebixa ) ESCA: For the treatment of Alzheimer s disease. SECONDARY CARE SECTION TO BE COMPLETED BY INITIATING DOCTOR
More informationPatients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by
Dementia is the permanent loss of multiple intellectual functions resulting from neuronal death. Dementia afflicts 10% of individuals over the age of 65 and these patients survive approximately seven years
More informationUpdate on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice
Update on guidelines on biological treatment of depressive disorder Dr. Henry CHEUNG Psychiatrist in private practice 2013 update International Task Force of World Federation of Societies of Biological
More informationSymptoms of mania can include: 3
Bipolar Disorder This factsheet gives information on bipolar disorder. It explains the symptoms of bipolar disorder, treatments and ways to manage symptoms. It also covers what treatment the National Institute
More informationMeeting the Needs of Aging Persons. Aging in Individuals with a
Meeting the Needs of Aging Persons with Developmental Disabilities Cross Network Collaboration for Florida Aging in Individuals with a Developmental Disability Module 3 Based on ADRC training developed
More informationDEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource
E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population
More informationManagement of Alzheimers Disease and Related Dementias
Management of Alzheimers Disease and Related Dementias Guidelines Being Compared: 1. American College of Physicians/American Academy of Family Physicians (ACP/AAFP). Current pharmacologic treatment of
More informationBipolar Disorder. Mania is the word that describes the activated phase of bipolar disorder. The symptoms of mania may include:
Bipolar Disorder What is bipolar disorder? Bipolar disorder, or manic depression, is a medical illness that causes extreme shifts in mood, energy, and functioning. These changes may be subtle or dramatic
More informationPerson-centered dementia care Old hats and new brooms. Professor Dawn Brooker Association for Dementia Studies University of Worcester UK
Person-centered dementia care Old hats and new brooms Professor Dawn Brooker Association for Dementia Studies University of Worcester UK A pair of old hats... Person Centred Care & BPSD Association for
More informationGuidelines for Dementia Syndrome
Guidelines for Dementia Syndrome Dementia is the chronic acquired decline in memory and at least one other cognitive function (e.g. language, visual-spatial, executive) sufficient to offset daily life.
More informationMOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines
MOH CLINICL PRCTICE GUIELINES 2/2008 Prescribing of Benzodiazepines College of Family Physicians, Singapore cademy of Medicine, Singapore Executive summary of recommendations etails of recommendations
More informationAlcohol and nicotine are widely abused substances and are often used together One study showed that 15% of patients visiting a primary care practice
Dr IM Joubert Alcohol and nicotine are widely abused substances and are often used together One study showed that 15% of patients visiting a primary care practice for any reason had either an at-risk pattern
More informationPARTNERING WITH YOUR DOCTOR:
PARTNERING WITH YOUR DOCTOR: A Guide for Persons with Memory Problems and Their Care Partners Alzheimer s Association Table of Contents PARTNERING WITH YOUR DOCTOR: When is Memory Loss a Problem? 2 What
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationEssential Shared Care Agreement Drugs for Dementia
Ref No. E040 Essential Shared Care Agreement Drugs for Dementia Please complete the following details: Patient s name, address, date of birth Consultant s contact details (p.3) And send One copy to: 1.
More informationA Manic Episode is defined by a distinct period during which there is an abnormally and persistently elevated, expansive, or irritable mood.
Bipolar disorder Bipolar (manic-depressive illness) is a recurrent mode disorder. The patient may feel stable at baseline level but experience recurrent shifts to an emotional high (mania or hypomania)
More informationMEDICATION ABUSE IN OLDER ADULTS
MEDICATION ABUSE IN OLDER ADULTS Clifford Milo Singer, MD Adjunct Professor, University of Maine, Orono ME Chief, Division of Geriatric Mental Health and Neuropsychiatry The Acadia Hospital and Eastern
More informationThis document presents the recommendations of an
SPECIAL ARTICLES Consensus Statement on Improving the Quality of Mental Health Care in U.S. Nursing Homes: Management of Depression and Behavioral Symptoms Associated with Dementia American Geriatrics
More informationDepre r s e sio i n o i n i a dults Yousuf Al Farsi
Depression in adults Yousuf Al Farsi Objectives 1. Aetiology 2. Classification 3. Major depression 4. Screening 5. Differential diagnosis 6. Treatment approach 7. When to refer 8. Complication 9. Prognosis
More informationObsessive Compulsive Disorder: a pharmacological treatment approach
Obsessive Compulsive Disorder: a pharmacological treatment approach Professor Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne Royal Children s Hospital
More informationNICE Clinical guideline 23
NICE Clinical guideline 23 Depression Management of depression in primary and secondary care Consultation on amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised
More informationManagement of benzodiazepine misuse
York Service Management of benzodiazepine misuse Version 2 JT July 2013 page 1 background Note: not all those who use benzodiazepines are dependent, and not all those who are dependent will benefit from
More informationDSM-5: A Comprehensive Overview
1) The original DSM was published in a) 1942 b) 1952 c) 1962 d) 1972 DSM-5: A Comprehensive Overview 2) The DSM provides all the following EXCEPT a) Guidelines for the treatment of identified disorders
More informationImproving the Recognition and Treatment of Bipolar Depression
Handout for the Neuroscience Education Institute (NEI) online activity: Improving the Recognition and Treatment of Bipolar Depression Learning Objectives Apply evidence-based tools that aid in differentiating
More informationNorth Bay Regional Health Centre
Addictions and Mental Health Division Programs Central Intake Referral Form The Central Intake Referral Form is used in the District of Nipissing by the North Bay Regional Health Centre s Addictions and
More informationGUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS
GUIDELINES GUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS Preamble The American Society of Consultant Pharmacists has developed these guidelines for use of psychotherapeutic medications
More informationDelirium Toolbox Inpatient/Outpatient high value care considerations. Birju B. Patel, MD, FACP, AGSF N. Wilson Holland, MD, FACP, AGSF
Delirium Toolbox Inpatient/Outpatient high value care considerations Birju B. Patel, MD, FACP, AGSF N. Wilson Holland, MD, FACP, AGSF Goals for this session Understand prevalence, differential diagnosis,
More informationDisclosures Christer Allgulander
How Patients With Generalized Anxiety Disorder (GAD) Are Treated in Specialized Care: A Pharmacoepidemiological Case Register Study in Sweden Christer Allgulander MD, Karolinska Institutet, Sweden Jan
More informationTECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management
TECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management WHY IS THIS IMPORTANT? Depression causes fluctuations in mood, low self esteem and loss of interest or pleasure in normally
More informationASSESSMENT AND MANAGEMENT OF PSYCHOSIS IN PERSONS WITH DEMENTIA
ASSESSMENT AND MANAGEMENT OF PSYCHOSIS IN PERSONS WITH DEMENTIA Overview: Psychosis is a common clinical feature of dementia. Hallucinations and delusions are the two most common types of psychotic symptoms
More informationMental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca
Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late
More informationBRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS
BRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems
More information2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease
2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease Dylan Wint, M.D. ALZHEIMER DISEASE Dylan Wint, M.D. Lou Ruvo Center for Brain Health DEFINITIONS Cognitive related to thinking,
More informationPsychopharmacotherapy for Children and Adolescents
TREATMENT GUIDELINES Psychopharmacotherapy for Children and Adolescents Guideline 7 Psychopharmacotherapy for Children and Adolescents Description There are few controlled trials to guide practitioners
More informationStep 4: Complex and severe depression in adults
Step 4: Complex and severe depression in adults A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive
More informationThis continuing education activity is co-sponsored by Indiana University School of Medicine and by CME Outfitters, LLC.
This continuing education activity is co-sponsored by Indiana University School of Medicine and by CME Outfitters, LLC. Indiana University School of Medicine and CME Outfitters, LLC, gratefully acknowledge
More informationBipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care
Issue date: July 2006 Bipolar disorder The management of bipolar disorder in adults, children and adolescents, in primary and secondary care NICE clinical guideline 38 Developed by the National Collaborating
More informationDelirium. The signs of delirium are managed by treating the underlying cause of the medical condition causing the delirium.
Delirium Introduction Delirium is a complex symptom where a person becomes confused and shows significant changes in behavior and mental state. Signs of delirium include problems with attention and awareness,
More informationNon-pharmacological Interventions and Behaviours that Challenge in Dementia: Reflections
Non-pharmacological Interventions and Behaviours that Challenge in Dementia: Reflections Adrian Lewis, Senior Occupational Therapist, Department of Old Age Psychiatry, HSE Dublin South Central alewis@stjames.ie
More informationChapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of
Chapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of antipsychotic agents Identify common adverse effects
More informationMental Health Needs Assessment Personality Disorder Prevalence and models of care
Mental Health Needs Assessment Personality Disorder Prevalence and models of care Introduction and definitions Personality disorders are a complex group of conditions identified through how an individual
More informationElizabeth A. Crocco, MD Assistant Clinical Professor Chief, Division of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Miller
Elizabeth A. Crocco, MD Assistant Clinical Professor Chief, Division of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Miller School of Medicine/University of Miami Question 1 You
More informationGeriatric Psychiatry Service Delivery: South Island - Island Health
Geriatric Psychiatry Service Delivery: South Island - Island Health Dine and Learn: Victoria Division of Family Practice November 23, 2015 Learning Objectives The Division of Geriatric Psychiatry South
More informationPost-traumatic stress disorder overview
Post-traumatic stress disorder overview A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive
More informationThe Pharmacist s Role in Recognition and Management of Alzheimer s
10:15am - 11:15am: Breakout 2 - Mental Health Option B: The Pharmacist s Role in Recognition and Management of Alzheimer s ACPE UAN 0107-0000-10-013-L01-P 0.1 CEU/1.0 Hr. Activity Type: Application-Based
More informationBENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM
3 rd Quarter 2015 BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM Introduction Benzodiazepines, sometimes called "benzos",
More informationNeuropsychiatry Disorders
Neuropsychiatry Disorders Larry Fisher, Ph.D., ABN UHS Neurobehavioral Systems (Copyright UHS 2009; All rights reserved) For more information: Larry Fisher, Ph.D., ABN UHS Neurobehavioral Systems 12710
More informationLewy body dementia Referral for a Diagnosis
THE Lewy Body society The more people who know, the fewer people who suffer Lewy body dementia Referral for a Diagnosis Lewy Body Dementias REFERRAL FOR A DIAGNOSIS In the UK people with all forms of dementia
More informationBEHAVIOURAL ASSESSMENT FORM PLACEMENT SERVICES
BEHAVIOURAL ASSESSMENT FORM PLACEMENT SERVICES Client Name: Date of Birth: HCN: Date of Completion: (Last Name, First Name) (Day/Month/Year) (Day/Month/Year) (Version Code) INSTRUCTIONS: Frequency scales
More informationTrends in Prescribing of Antipsychotic Drugs in General Practice in England (Chart 1) 2.0. Other second generation antipsychotics (SGA)
Antipsychotic drugs Antipsychotics can be broadly classified into first generation antipsychotics (FGAs, formerly known as typical antipsychotics) and second generation antipsychotics (SGAs, formerly known
More information